Higher Aminopeptidase Activity Determined by Electroosmotic Push-Pull Perfusion Contributes to Selective Vulnerability of the Hippocampal CA1 Region to Oxygen Glucose Deprivation

ACS Chemical Neuroscience
Y Ou, S G Weber

Abstract

It has been known for over a century that the hippocampus, the center for learning and memory in the brain, is selectively vulnerable to ischemic damage, with the CA1 being more vulnerable than the CA3. It is also known that leucine enkephalin, or YGGFL, is neuroprotective. We hypothesized that the extracellular hydrolysis of YGGFL may be greater in the CA1 than the CA3, which would lead to the observed difference in susceptibility to ischemia. In rat organotypic hippocampal slice cultures, we estimated the Michaelis constant and the maximum velocity for membrane-bound aminopeptidase activity in the CA1 and CA3 regions. Using electroosmotic push-pull perfusion and offline capillary liquid chromatography, we inferred enzyme activity based on the production rate of GGFL, a natural and inactive product of the enzymatic hydrolysis of YGGFL. We found nearly 3-fold higher aminopeptidase activity in the CA1 than the CA3. The aminopeptidase inhibitor bestatin significantly reduced hydrolysis of YGGFL in both regions by increasing apparent Km. Based on propidium iodide cell death measurements 24 h after oxygen-glucose deprivation, we demonstrate that inhibition of aminopeptidase activity using bestatin selectively protected CA1 against ...Continue Reading

References

Jan 1, 1991·Neuroscience·R Schmidt-Kastner, T F Freund
Jan 1, 1990·International Review of Cytology·A K Thureson-Klein, R L Klein
Jan 28, 1991·Neuroscience Letters·A MitaniK Kataoka
Jan 30, 1989·Neuroscience Letters·K Magnusson, T Wieloch
Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·G WaksmanB P Roques
May 1, 1982·Annals of Neurology·W A PulsinelliF Plum
Aug 1, 1996·Trends in Pharmacological Sciences·C S Konkoy, T P Davis
Jun 1, 1996·Neuroscience·K P MayfieldF Porreca
Aug 11, 1999·Trends in Neurosciences·U DirnaglM A Moskowitz
May 9, 2002·American Journal of Physiology. Cell Physiology·Junhui ZhangYing Xia
Jul 5, 2003·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Wulf Paschen
Feb 1, 1962·Journal of Neurology, Neurosurgery, and Psychiatry·J B BRIERLEY, J E COOPER
Feb 3, 2004·Current Topics in Medicinal Chemistry·Anna JaneckaTomasz Janecki
Jun 11, 2004·European Journal of Pharmacology·Dongwook SonSun Yeou Kim
Jun 29, 2004·International Review of Cytology·Rolf Mentlein
Jan 27, 2005·Neurochemistry International·G LarrinagaJ Irazusta
Feb 1, 2005·Annals of the New York Academy of Sciences·Natalia N NalivaevaaAnthony J Turner
Aug 17, 2005·Current Drug Targets. CNS and Neurological Disorders·Jens NorabergJens Zimmer
May 13, 2006·Stroke; a Journal of Cerebral Circulation·Anna RosellJoan Montaner
Aug 24, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Donald J DeGracia, Bingren R Hu
Oct 6, 2006·Journal of Neuropathology and Experimental Neurology·Ping ZhaoZhiyi Zuo
Nov 15, 2006·Proceedings of the National Academy of Sciences of the United States of America·Anne WisnerCatherine Rougeot
Apr 5, 2007·Nature Protocols·Nadine GogollaPico Caroni
Mar 11, 2009·Free Radical Biology & Medicine·Shinji OikawaTetsumori Yamashima
Jun 17, 2010·Frontiers in Aging Neuroscience·Xinkun Wang, Elias K Michaelis
Aug 12, 2010·Analytical Chemistry·Amy E HamsherStephen G Weber

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.